Literature DB >> 869103

Inhibition of the immune response to whooping cough and tetanus vaccines by malaria infection, and the effect of pertussis adjuvant.

A Tarzaali, P Viens, M Quevillon.   

Abstract

Plasmodium yoelii infection of mice depressed their capacity to build up humoral immune response to diphteria vaccine and protective immunity against tetanus toxin. This immunodepression was overcome by Freund's complete adjuvant or killed pertussis bacilli (whooping cough vaccine). These results suggest that vaccines should be given in association in malaria endemic area.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 869103     DOI： 10.4269/ajtmh.1977.26.520

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  6 in total

1.  Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.

Authors:  F Simondon; A Yam; J Y Gagnepain; S Wassilak; B Danve; M Cadoz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 2.  Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

Authors:  V Dietz; A Galazka; F van Loon; S Cochi
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Immunodepression of thymus-independent response to dextran in mouse malaria.

Authors:  J S McBride; H S Micklem
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Enhanced Toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children.

Authors:  Franca C Hartgers; Benedicta B Obeng; Astrid Voskamp; Irene A Larbi; Abena S Amoah; Adrian J F Luty; Daniel Boakye; Maria Yazdanbakhsh
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

5.  Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Authors:  Jennifer B Rosen; Joel G Breman; Charles R Manclark; Bruce D Meade; William E Collins; Hans O Lobel; Pierre Saliou; Jacquelin M Roberts; Pierre Campaoré; Mark A Miller
Journal:  Malar J       Date:  2005-11-06       Impact factor: 2.979

6.  A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.

Authors:  Matthew B Laurens; Sodiomon B Sirima; Elizabeth T Rotrosen; Mohamadou Siribie; Alfred Tiono; Alphonse Ouedraogo; Yuanyuan Liang; Leslie P Jamka; Karen L Kotloff; Kathleen M Neuzil
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.